Adverse events among patients undergoing stem cell therapy for orthopedic conditions
A multi-center analysis of adverse events among 2,372 adult patients undergoing adult autologous stem cell therapy for orthopedic conditions. The purpose of the present investigation is to report on detailed …
Autologous Bone Marrow Concentrate for the Treatment of Shoulder Rotator Cuff Tears and Osteoarthritis
A prospective multi-site registry study of a specific protocol of autologous bone marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis Shoulder pain is a common musculoskeletal …
Adult Autologous Stem Cell Therapy for Orthopaedic Conditions
A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions Autologous mesenchymal stem cells (MSCs) …
Europe approves the first stem cell-based medicinal product
The European Commission has given Holoclar®, the first advanced therapy medicinal product (ATMP) containing stem cells, conditional marketing authorisation following a recommendation for approval by the European Medicines Agency. Holoclar® …
This is the conference I heard about on Good Morning America
Vatican Conference Hopes to Promote Truth on Adult Stem Cell Therapy Doctors, Patients Speak on Personal Experiences During today’s first session of the Second International Vatican Adult Stem Cell Conference, …
Anti-Aging: The Future of Medicine is Here Now!
Dr. Ahvie Herskowitz is speaking this weekend, Saturday April 30, 1:00 – 2:30 pm at the New Living Expo in San Mateo, about Anti-Aging: The Future of Medicine is Here …